-
1 Comment
Japan Animal Referral Medical Center Co., Ltd is currently in a long term downtrend where the price is trading 12.7% below its 200 day moving average.
From a valuation standpoint, the stock is 67.0% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 1.8.
Japan Animal Referral Medical Center Co., Ltd's total revenue rose by 4.5% to $721M since the same quarter in the previous year.
Its net income has dropped by 18.2% to $69M since the same quarter in the previous year.
Based on the above factors, Japan Animal Referral Medical Center Co., Ltd gets an overall score of 1/5.
| ISIN | JP3740000009 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| PE Ratio | 27.17 |
|---|---|
| Target Price | 2350 |
| Dividend Yield | 0.8% |
| Market Cap | 14B |
| Beta | 0.27 |
Japan Animal Referral Medical Center Co., Ltd., together with its subsidiaries, owns and operates animal hospitals that provide advanced medical treatment for dogs and cats in Japan. The company's medical centers consist of cardiology, respiratory, urology, gastroenterology, oncology, neurology, orthopedics, ophthalmology, radiology and imaging, and anesthesiology departments. It also provides professional training services for veterinarian training and education for advanced medical treatments; and conducts research and development projects, including genetic testing, immunotherapy, and regenerative medicine. Japan Animal Referral Medical Center Co., Ltd. was incorporated in 2005 and is headquartered in Kawasaki, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6039.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026